ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,325, issued on Aug. 4.
"Biological binding molecules" was invented by Holger Klapproth (Freiburg i. Br., Germany), Marc A. Kessemeier (Emmendingen, Germany) and Ulrich Birsner (Freiburg i. Br., Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of the preparation, identification and selection of biological binding molecules such as antibodies or fragments thereof, and also the use thereof in the context of therapy and prophylaxis of cancers, such as malignant B-cell neoplasia in particular. The binding molecules are capable of selectively binding to B-cell receptors that have a light chain according to SEQ ID NO...